Background: Epidemiologic studies reveal a dramatic increase in allergies in the last decades. Air pollution is considered to be one of the factors responsible for this augmentation. The aim of this study was to analyze the impact of urbanization on birch pollen. The birch pollen proteome was investigated in order to identify differences in protein abundance between pollen from rural and urban areas. The allergenicity of birch pollen from both areas was evaluated by assessing its chemotactic potency as well as its protein and allergen contents. Methods: Difference gel electrophoresis (DIGE) was used to analyze the pollen proteome. The chemotactic activity of aqueous pollen extracts was determined by migration assays of human neutrophils. Results: DIGE revealed 26 differences in protein spot intensity between pollen from urban and rural areas. One of these proteins was identified by de novo sequencing as the 14-3-3 protein, which resembles a stress-induced factor in other plant species. Furthermore, extracts from pollen collected in urban areas had higher chemotactic activity on human neutrophils compared to pollen from rural sites. Conclusions: The present study points to an impact of air pollution on allergen carrier proteome and release of chemotactic substances. The increment in proinflammatory substances such as pollen-associated lipid mediators might contribute to the described urban-rural gradient of allergy prevalence. Furthermore, our study suggests that allergenicity is determined by more than the sole allergen content.

Keywords:
Allergy, Birch pollen, Difference gel electrophoresis, Pollution, Two-dimensional polyacrylamide electrophoresis
1.
Ring J, Krämer U, Schäfer T, Behrendt H: Why are allergies increasing? Curr Opin Immunol 2001;13:701–708.
2.
Van Niekerk CH, Weinberg EG, Shore SC, Heese HV, Van Schalkwyk J: Prevalence of asthma: a comparative study of urban and rural Xhosa children. Clin Allergy 1979;9:319–324.
3.
Yemaneberhan H, Bekele Z, Venn A, Lewis S, Parry E, Britton J: Prevalence of wheeze and asthma and relation to atopy in urban and rural Ethiopia. Lancet 1997;350:85–90.
4.
Addo Yobo EO, Custovic A, Taggart SC, Asafo-Agyei AP, Woodcock A: Exercise-induced bronchospasm in Ghana: differences in prevalence between urban and rural schoolchildren. Thorax 1997;52:161–165.
5.
Ishizaki T, Koizumi K, Ikemori R, Ishiyama Y, Kushibiki E: Studies of prevalence of Japanese cedar pollinosis among the residents in a densely cultivated area. Ann Allergy 1987;58:265–270.
6.
Krämer U, Koch T, Ranft U, Ring J, Behrendt H: Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology 2000;11:64–70.
7.
Saxon A, Diaz-Sanchez D: Air pollution and allergy: you are what you breathe. Nat Immunol 2005;6:223–226.
8.
Riedl MA, Landaw EM, Saxon A, Diaz-Sanchez D: Initial high-dose nasal allergen exposure prevents allergic sensitization to a neoantigen. J Immunol 2005;174:7440–7445.
9.
Diaz-Sanchez D, Garcia MP, Wang M, Jyrala M, Saxon A: Nasal challenge with diesel exhaust particles can induce sensitization to a neoallergen in the human mucosa. J Allergy Clin Immunol 1999;104:1183–1188.
10.
Ahlholm JU, Helander ML, Savolainen J: Genetic and environmental factors affecting the allergenicity of birch (Betula pubescens ssp. czerepanovii [Orl.] Hamet-ahti) pollen. Clin Exp Allergy 1998;28:1384–1388.
11.
Helander ML, Savolainen J, Ahlholm J: Effects of air pollution and other environmental factors on birch pollen allergens. Allergy 1997;52:1207–1214.
12.
Hjelmroos M, Schumacher MJ, Van Hage-Hamsten M: Heterogeneity of pollen proteins within individual Betula pendula trees. Int Arch Allergy Immunol 1995;108:368–376.
13.
Behrendt H, Becker WM: Localization, release and bioavailability of pollen allergens: the influence of environmental factors. Curr Opin Immunol 2001;13:709–715.
14.
Behrendt H, Becker WM, Fritzsche C, Sliwa-Tomczok W, Tomczok J, Friedrichs KH, Ring J: Air pollution and allergy: experimental studies on modulation of allergen release from pollen by air pollutants. Int Arch Allergy Immunol 1997;113:69–74.
15.
Behrendt H, Tomczok J, Sliwa-Tomczok W, Kasche A, Ebner von Eschenbach C, Becker WM, Ring J: Timothy grass (Phleum pratense L.) pollen as allergen carriers and initiators of an allergic response. Int Arch Allergy Immunol 1999;118:414–418.
16.
Motta AC, Marliere M, Peltre G, Sterenberg PA, Lacroix G: Traffic-related air pollutants induce the release of allergen-containing cytoplasmic granules from grass pollen. Int Arch Allergy Immunol 2006;139:294–298.
17.
Ruffin J, Liu MY, Sessoms R, Banerjee S, Banerjee UC: Effects of certain atmospheric pollutants (SO2, NO2 and CO) on the soluble amino acids, molecular weight and antigenicity of some airborne pollen grains. Cytobios 1986;46:119–129.
18.
Franze T, Weller MG, Niessner R, Poschl U: Protein nitration by polluted air. Environ Sci Technol 2005;39:1673–1678.
19.
Gruijthuijsen YK, Grieshuber I, Stocklinger A, Tischler U, Fehrenbach T, Weller MG, Vogel L, Vieths S, Poschl U, Duschl A: Nitration enhances the allergenic potential of proteins. Int Arch Allergy Immunol 2006;141:265–275.
20.
Deb R, Shakib F, Reid K, Clark H: Major house dust mite allergens Der p 1 and Der f 1 degrade and inactivate lung surfactant proteins-A and -D. J Biol Chem 2007;282:36808–36819.
21.
Traidl-Hoffmann C, Kasche A, Menzel A, Jakob T, Thiel M, Ring J, Behrendt H: Impact of pollen on human health: more than allergen carriers? Int Arch Allergy Immunol 2003;131:1–13.
22.
Traidl-Hoffmann C, Jakob T, Behrendt H: Determinants of allergenicity. J Allergy Clin Immunol 2009.
23.
Boldogh I, Bacsi A, Choudhury BK, Dharajiya N, Alam R, Hazra TK, Mitra S, Goldblum RM, Sur S: ROS generated by pollen NADPH oxidase provide a signal that augments antigen-induced allergic airway inflammation. J Clin Invest 2005;115:2169–2179.
24.
Dharajiya N, Choudhury BK, Bacsi A, Boldogh I, Alam R, Sur S: Inhibiting pollen reduced nicotinamide adenine dinucleotide phosphate oxidase-induced signal by intrapulmonary administration of antioxidants blocks allergic airway inflammation. J Allergy Clin Immunol 2007;119:646–653.
25.
Traidl-Hoffmann C, Kasche A, Jakob T, Huger M, Plotz S, Feussner I, Ring J, Behrendt H: Lipid mediators from pollen act as chemoattractants and activators of polymorphonuclear granulocytes. J Allergy Clin Immunol 2002;109:831–838.
26.
Plötz SG, Traidl-Hoffmann C, Feussner I, Kasche A, Feser A, Ring J, Jakob T, Behrendt H: Chemotaxis and activation of human peripheral blood eosinophils induced by pollen-associated lipid mediators. J Allergy Clin Immunol 2004;113:1152–1160.
27.
Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, Mueller MJ, Jakob T, Behrendt H: Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 2005;201:627–636.
28.
Mariani V, Gilles S, Jakob T, Thiel M, Mueller MJ, Ring J, Behrendt H, Traidl-Hoffmann C: Immunomodulatory mediators from pollen enhance the migratory capacity of dendritic cells and license them for Th2 attraction. J Immunol 2007;178:7623–7631.
29.
Gutermuth J, Bewersdorff M, Traidl-Hoffmann C, Ring J, Mueller MJ, Behrendt H, Jakob T: Immunomodulatory effects of aqueous birch pollen extracts and phytoprostanes on primary immune responses in vivo. J Allergy Clin Immunol 2007;120:293–299.
30.
Vos P, Hogers R, Bleeker M, Reijans M, van de Lee T, Hornes M, Frijters A, Pot J, Peleman J, Kuiper M, et al: AFLP: a new technique for DNA fingerprinting. Nucleic Acids Res 1995;23:4407–4414.
31.
Arens P, Coops H, Jansen J, Vosman B: Molecular genetic analysis of black poplar (Populus nigra L.) along Dutch rivers. Mol Ecol 1998;7:11–18.
32.
Schenk MF, Thienpont CN, Koopman WJM, Gilissen LJWJ, Smulders MJM: Phylogenetic relationships in Betula (Betulaceae) based on AFLP markers. Tree Genet Genom 2008;4:911–924.
33.
Bonin A, Bellemain E, Bronken Eidesen P, Pompanon F, Brochmann C, Taberlet P: How to track and assess genotyping errors in population genetics studies. Mol Ecol 2004;13:3261–3273.
34.
Palmes ED, Gunnison AF, DiMattio J, Tomczyk C: Personal sampler for nitrogen dioxide. Am Ind Hyg Assoc J 1976;37:570–577.
35.
Görg A, Boguth G, Obermaier C, Weiss W: Two-dimensional electrophoresis of proteins in an immobilized pH 4–12 gradient. Electrophoresis 1998;19:1516–1519.
36.
Görg A, Weiss W, Dunn MJ: Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004;4:3665–3685.
37.
Wildgruber R, Reil G, Drews O, Parlar H, Görg A: Web-based two-dimensional database of Saccharomyces cerevisiae proteins using immobilized pH gradients from pH 6 to pH 12 and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002;2:727–732.
38.
Drews O, Weiss W, Reil G, Parlar H, Wait R, Görg A: High pressure effects step-wise altered protein expression in Lactobacillus sanfranciscensis. Proteomics 2002;2:765–774.
39.
Buters JT, Kasche A, Weichenmeier I, Schober W, Klaus S, Traidl-Hoffmann C, Menzel A, Huss-Marp J, Kramer U, Behrendt H: Year-to-year variation in release of Bet v 1 allergen from birch pollen: evidence for geographical differences between West and South Germany. Int Arch Allergy Immunol 2008;145:122–130.
40.
Alban A, David SO, Bjorkesten L, Andersson C, Sloge E, Lewis S, Currie I: A novel experimental design for comparative two-dimensional gel analysis: two-dimensional difference gel electrophoresis incorporating a pooled internal standard. Proteomics 2003;3:36–44.
41.
Armentia A, Lombardero M, Callejo A, Barber D, Martin Gil FJ, Martin-Santos JM, Vega JM, Arranz ML: Is Lolium pollen from an urban environment more allergenic than rural pollen? Allergol Immunopathol (Madr) 2002;30:218–224.
42.
Cortegano I, Civantos E, Aceituno E, del Moral A, Lopez E, Lombardero M, del Pozo V, Lahoz C: Cloning and expression of a major allergen from Cupressus arizonica pollen, Cup a 3, a PR-5 protein expressed under polluted environment. Allergy 2004;59:485–490.
43.
Suárez-Cervera M, Castells T, Vega-Maray A, Civantos E, del Pozo V, Fernández-González D, Moreno-Grau S, Moral A, López-Iglesias C, Lahoz C, Seoane-Camba JA: Effects of air pollution on Cup a 3 allergen in Cupressus arizonica pollen grains. Ann Allergy Asthma Immunol 2008;101:57–66.
44.
Majd A, Chehregani A, Moin M, Gholami M, Kohono S, Nabe T, Shariatzade MA: The effects of air pollution on structures, proteins and allergenicity of pollen grains. Aerobiologia 2004;20:111–118.
45.
Behrendt H, Tomczok J, Sliwa-Tomczok W, Kasche A, Ebner von Eschenbach C, Becker WM, Ring J: Timothy grass (Phleum pratense L.) pollen as allergen carriers and initiators of an allergic response. Int Arch Allergy Immunol 1999;118:414–418.
46.
Chehregani A, Majde A, Moin M, Gholami M, Ali Shariatzadeh M, Nassiri H: Increasing allergy potency of Zinnia pollen grains in polluted areas. Ecotoxicol Environ Saf 2004;58:267–272.
47.
Holtman WL, Roberts MR, Oppedijk BJ, Testerink C, van Zeijl MJ, Wang M: 14-3-3 proteins interact with a 13-lipoxygenase, but not with a 9-lipoxygenase. FEBS Lett 2000;474:48–52.
48.
Holtman WL, Roberts MR, Wang M: 14-3-3 proteins and a 13-lipoxygenase form associations in a phosphorylation-dependent manner. Biochem Soc Trans 2000;28:834–836.
© 2009 S. Karger AG, Basel
2009
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.